Supply Chain
New research from Advisory Board, conducted in partnership with Staples Business, reveals how 102 health system supply chain and executive…
Patients with cancer are often extremely ill, emotionally distressed and vulnerable. Medical oncologists routinely prescribe medications that are extraordinarily expensive, and patently unaffordable at full market price.
Craig E. Devoe, MD, Acting Chief, Division of Hematology and Medical Oncology, Northwell Health
Biotech stocks have been on the rise since news outlets reported that President Donald Trump's executive order tackling drug prices will contain industry-friendly policies, according to Bloomberg Politics.
Here are six articles published by Becker's Hospital Review this week, highlighting President Donald Trump's executive order on drug pricing, Amazon's acquisition of Whole Foods and more.
Merck and Premier will build on an existing partnership to create and test the efficacy of data-driven care solutions for at-risk patient populations.
Food and Drug Administration Commissioner Scott Gottlieb, MD, on Wednesday authored a blog post on the agency's website highlighting strategies to promote generic drug competition.
Lucid Pharmaceuticals recalled more than 69,000 bottles of its extended-release antidepressant drug cenlafaxine hydrochloride over quality concerns.
Mylan banks on more than just prescription medications to make a profit. The drugmaker has achieved hundreds of millions of dollars in tax credits over the last six years by investing in refined coal, reports Reuters.
The Food and Drug Administration on Tuesday approved Shire's attention deficit hyperactivity disorder treatment, Mydayis.
The Food and Drug Administration will eliminate its backlog of orphan drug designation requests within the next two months, according to FDA Commissioner Scott Gottlieb, MD.
A draft of President Donald Trump's executive order on drug prices lists several proposals to roll back regulatory hurdles for the pharmaceutical industry, reports The New York Times.